|
[1]
|
曹彬, 丰义宽, 李国庆. 轻微肝性脑病的诊断与治疗进展[J]. 现代消化及介入诊疗, 2006, 11(4): 239-242.
|
|
[2]
|
Gimenez-Garzo, C., Garces, J.J., Urios, A., et al. (2017) The PHES Battery Does Not Detect All Cir-rhotic Patients with Early Neurological Deficits, Which Are Different in Different Patients. PLOS ONE, 12, e0171211. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
谢丛, 马敏阁, 孟毓珊, 等. 肝性脑病的影像学表现研究现状[J]. 分子影像学杂志, 2022, 45(2): 289-293.
|
|
[4]
|
鲁冰洁, 赵亚红, 安泳潼, 等. 肠道微生物在肝硬化及相关并发症中的研究进展[J]. 临床肝胆病杂志, 2018, 34(11): 2433-2437.
|
|
[5]
|
季利江. 乳果糖氢呼气试验测定口盲通过时间在慢性功能性便秘诊断及分类中的价值[D]: [硕士学位论文]. 南京: 南京中医药大学, 2005.
|
|
[6]
|
秦子文, 刘晶涛, 范晓红, 等. 肠道菌群与肝性脑病的关系[J]. 胃肠病学和肝病学杂志, 2021, 30(1): 34-37.
|
|
[7]
|
Massey, B.T. and Wald, A. (2021) Small Intestinal Bacterial Overgrowth Syndrome: A Guide for the Appropriate Use of Breath Testing. Digestive Diseases and Sciences, 66, 338-347. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
郭栗良子, 王立生. 肝硬化患者肠道菌群失衡的研究现状[J]. 中国微生态学杂志, 2018, 30(1): 104-108, 113.
|
|
[9]
|
Oumi, M. and Yamamoto, T. (2000) A Scanning Electron Microscope Study on the Effects of Different Bile Salts on the Epi-thelial Lining of Jejunal Mucosa. Medical Electron Microscopy, 33, 11-15. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Ghosh, G. and Jesudian, A.B. (2019) Small Intestinal Bacterial Over-growth in Patients with Cirrhosis. Journal of Clinical and Experimental Hepatology, 9, 257-267. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Galati, J. S., Holdeman, K.P., Bottjen, P.L., et al. (1997) Gastric Emptying and Orocecal Transit in Portal Hypertension and End-Stage Chronic Liver Disease. Liver Transplantation and Surgery, 3, 34-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Morencos, F.C., De Las Heras Castano, G., Martin Ramos, L., et al. (1995) Small Bowel Bacterial Overgrowth in Patients with Alcoholic Cirrhosis. Digestive Diseases and Sciences, 40, 1252-1256. [Google Scholar] [CrossRef]
|
|
[13]
|
Liu, Q., Duan, Z.P., Ha, D.K., et al. (2004) Synbiotic Mod-ulation of Gut Flora: Effect on Minimal Hepatic Encephalopathy in Patients with Cirrhosis. Hepatology, 39. 1441-1449. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Gupta, A., Dhiman, R.K., Kumari, S., et al. (2010) Role of Small Intestinal Bacterial Overgrowth and Delayed Gastrointestinal Transit Time in Cirrhotic Patients with Minimal Hepatic Encephalo-pathy. Journal of Hepatology, 53, 849-855. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Chesta, J., Silva, M., Thompson, L., et al. (1991) [Bacterial Overgrowth in Small Intestine in Patients with Liver Cirrhosis. Revista Médica de Chile, 119, 626-632.
|
|
[16]
|
Lunia, M.K., Sharma, B.C. and Sachdeva, S. (2013) Small Intestinal Bacterial Overgrowth and Delayed Orocecal Transit Time in Patients with Cirrhosis and Low-Grade Hepatic Encephalopathy. Hepatology In-ternational, 7, 268-273. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Pande, C., Kumar, A. and Sarin, S.K. (2009) Small-Intestinal Bacterial Overgrowth in Cirrhosis Is Related to the Severity of Liver Disease. Alimentary Pharmacology & Therapeutics, 29, 1273-1281. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
曹彬, 王玉, 丰义宽, 等. 小肠细菌过度生长相关性轻微肝性脑病患者的血浆内毒素水平[J]. 胃肠病学和肝病学杂志, 2009, 18(7): 618-620.
|
|
[19]
|
曹彬, 丰义宽, 李国庆. 肝硬化患者小肠细菌过度生长与轻微肝性脑病的相关性研究[J]. 国际内科学杂志, 2008, 35(2): 65-67.
|
|
[20]
|
Roland, B.C., Ciarleglio, M.M., Clarke, J.O., et al. (2015) Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth. Journal of Clinical Gastroenterology, 49, 571-576. [Google Scholar] [CrossRef]
|
|
[21]
|
Van Thiel, D.H., Fagiuoli, S., Wright, H.I., et al. (1994) Gastrointestinal Transit in Cirrhotic Patients: Effect of Hepatic Encephalopathy and Its Treatment. Hepatology, 19, 67-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Madrid, A.M., Brahm, J., Buckel, E., et al. (1997) Orthotopic Liver Transplantation Improves Small Bowel Motility Disorders in Cirrhotic Patients. The American Journal of Gastroenter-ology, 92, 1044-1045.
|
|
[23]
|
Ding, X.W., Liu, Y.X., Fang, X.C., et al. (2017) The Relationship between Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome. European Review for Medical and Pharmacological Sciences, 21, 5191-5196.
|
|
[24]
|
Pisarek, W. (2021) Minimal Hepatic Encephalopathy—Diagnosis and Treatment. Przegląd Gastroen-terologiczny, 16, 311-317. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Zhang, Y., Feng, Y., Cao, B., et al. (2015) Effects of SIBO and Rifaximin Therapy on MHE Caused by Hepatic Cirrhosis. International Journal of Clinical and Experimental Medicine, 8, 2954-2957.
|
|
[26]
|
Yokoyama, K., Sakamaki, A., Takahashi, K., et al. (2022) Hydro-gen-Producing Small Intestinal Bacterial Overgrowth Is Associated with Hepatic Encephalopathy and Liver Function. PLOS ONE, 17, e0264459. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Bajaj, J.S., Heuman, D.M., Wade, J.B., et al. (2011) Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients with Minimal Hepatic Encephalopathy. Gas-troenterology, 140, 478-487.E1. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Sidhu, S.S., Goyal, O., Mishra, B.P., et al. (2011) Rifaximin Im-proves Psychometric Performance and Health-Related Quality of Life in Patients with Minimal Hepatic Encephalopathy (The RIME Trial). American Journal of Gastroenterology, 106, 307-316. [Google Scholar] [CrossRef] [PubMed]
|